Prothena Biosciences

Prothena Biosciences is a United States-based biotechnology company that specializes in developing novel therapeutics for neurodegenerative diseases, such as Alzheimer's, Parkinson's, and amyloidosis. The company's research focuses on understanding the biology of misfolded proteins and leveraging this expertise to advance a diverse pipeline of drug candidates targeting protein dysregulation.